Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.

Article  CAS  PubMed  Google Scholar 

Barbhaiya M, Zuily S, Naden R, et al. 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023;82:1258–70.

Article  CAS  PubMed  Google Scholar 

Devreese KMJ, de Groot PG, de Laat B, et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18:2828–39.

Article  CAS  PubMed  Google Scholar 

Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Béguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4–15.

Article  CAS  PubMed  Google Scholar 

Hemker HC, Al Dieri R, De Smedt E, Béguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost. 2006;96:553–61.

Article  CAS  PubMed  Google Scholar 

Lecompte T, Wahl D, Perret-Guillaume C, Hemker HC, Lacolley P, Regnault V. Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk. Haematologica. 2007;92:714–5.

Article  PubMed  Google Scholar 

Regnault V, Béguin S, Wahl D, de Maistre E, Coenraad Hemker H, Lecompte T. Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thromb Haemost. 2003;89:208–12.

Article  CAS  PubMed  Google Scholar 

•• Zuily S, de Laat B, Guillemin F, et al. Anti-domain I β2-glycoprotein I antibodies and activated protein C resistance predict thrombosis in antiphospholipid syndrome: TAC(I)T Study. J Appl Lab Med. 2020;5:1242–52. Important study which had evaluated APC resistance in prospective cohort of APS/aPL patients.

Article  PubMed  Google Scholar 

•• Zuily S, Regnault V, Guillemin F, Kaminsky P, Rat A-C, Lecompte T, Wahl D. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study. Thromb Res. 2013;132:e1-7. Important study which had evaluated APC resistance in prospective cohort of APS/aPL patients.

Article  CAS  PubMed  Google Scholar 

Hemker HC, Béguin S. Phenotyping the clotting system. Thromb Haemost. 2000;84:747–51.

Article  CAS  PubMed  Google Scholar 

Hemker HC, Giesen PL, Ramjee M, Wagenvoord R, Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost. 2000;83:589–91.

Article  CAS  PubMed  Google Scholar 

Binder NB, Depasse F, Mueller J, Wissel T, Schwers S, Germer M, Hermes B, Turecek PL. Clinical use of thrombin generation assays. J Thromb Haemost. 2021;19:2918–29.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ninivaggi M, de Laat-Kremers R, Tripodi A, Wahl D, Zuily S, Dargaud Y, Ten Cate H, Ignjatović V, Devreese KMJ, de Laat B. Recommendations for the measurement of thrombin generation: communication from the ISTH SSC Subcommittee on lupus anticoagulant/antiphospholipid antibodies. J Thromb Haemost. 2021;19:1372–8.

Article  CAS  PubMed  Google Scholar 

Hansson KM, Nielsen S, Elg M, Deinum J. The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood. J Thromb Haemost. 2014;12:1678–86.

Article  CAS  PubMed  Google Scholar 

Dargaud Y, Trzeciak MC, Bordet JC, Ninet J, Negrier C. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost. 2006;96:562–7.

Article  CAS  PubMed  Google Scholar 

Mann KG, Whelihan MF, Butenas S, Orfeo T. Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost. 2007;5:2055–61.

Article  CAS  PubMed  Google Scholar 

•• Gehlen R, Vandevelde A, de Laat B, Devreese KMJ. Application of the thrombin generation assay in patients with antiphospholipid syndrome: a systematic review of the literature. Front Cardiovasc Med. 2023;10:1075121. The last major systematic review about APS and TGA.

Article  PubMed  PubMed Central  Google Scholar 

Subcommittee on Control of Anticoagulation of the SSC of the ISTH. Towards a recommendation for the standardization of the measurement of platelet-dependent thrombin generation. J Thromb Haemost. 2011;9:1859–61.

Article  Google Scholar 

Rodgers SE, Wong A, Gopal RD, Dale BJ, Duncan EM, McRae SJ. Evaluation of pre-analytical variables in a commercial thrombin generation assay. Thromb Res. 2014;134:160–4.

Article  CAS  PubMed  Google Scholar 

Devreese K, Peerlinck K, Arnout J, Hoylaerts MF. Laboratory detection of the antiphospholipid syndrome via calibrated automated thrombography. Thromb Haemost. 2009;101:185–96.

Article  CAS  PubMed  Google Scholar 

Besser M, Baglin C, Luddington R, van Hylckama VA, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study. J Thromb Haemost. 2008;6:1720–5.

Article  CAS  PubMed  Google Scholar 

Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study. J Thromb Haemost. 2009;7:1639–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaturvedi S, McCrae KR. Clinical risk assessment in the antiphospholipid syndrome: current landscape and emerging biomarkers. Curr Rheumatol Rep. 2017;19:43.

Article  PubMed  Google Scholar 

Billoir P, Miranda S, Levesque H, Benhamou Y, Le Cam DV. Hypercoagulability evaluation in antiphospholipid syndrome without anticoagulation treatment with thrombin generation assay: a preliminary study. J Clin Med. 2021;10:2728.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pengo V, Ruffatti A, Legnani C, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost. 2010;8:237–42.

Article  CAS  PubMed  Google Scholar 

Pengo V, Ruffatti A, Legnani C, et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011;118:4714–8.

Article  CAS  PubMed  Google Scholar 

Radin M, Barinotti A, Cecchi I, Foddai SG, Rubini E, Roccatello D, Menegatti E, Sciascia S. Thrombin generationassay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. J Clin Pathol. 2023;76(12):839–46. https://doi.org/10.1136/jcp-2022-208199.

Article  CAS  PubMed  Google Scholar 

Cheng C, Pontara E, Tonello M, Cattini MG, Bison E, Denas G, Pengo V. Antibody profiles comprising anti phosphatidylserine/prothrombin differently affect thrombin generation and protein C resistance in antiphospholipid antibody carriers. Clin Chim Acta. 2020;510:796–801.

Article  CAS  PubMed  Google Scholar 

Pontara E, Cattini MG, Bison E, Cheng C, Denas G, Pengo V. Antiphospholipid syndrome: Reversal of antiphosphatidylserine/prothrombin-induced activated protein C resistance. Thromb Res. 2022;218:17–23.

Article  CAS  PubMed  Google Scholar 

Pengo V, Del Ross T, Ruffatti A, et al. Lupus anticoagulant identifies two distinct groups of patients with different antibody patterns. Thromb Res. 2018;172:172–8.

Article  CAS  PubMed  Google Scholar 

Liestøl S, Sandset PM, Mowinckel M-C, Wisløff F. Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. J Thromb Haemost. 2007;5:2204–10.

Article  PubMed  Google Scholar 

Regnault V, Hemker HC, Wahl D, Lecompte T. Phenotyping the haemostatic system by thrombography–potential for the estimation of thrombotic risk. Thromb Res. 2004;114:539–45.

Article  CAS  PubMed  Google Scholar 

Müller-Calleja N, Hollerbach A, Royce J, et al. Lipid presentation by the protein C receptor links coagulation with autoimmunity. Science. 2021;371:eabc095.

Article  Google Scholar 

Kremers RMW, Zuily S, Kelchtermans H, Peters TC, Bloemen S, Regnault V, Hemker HC, de Groot PG, Wahl D, de Laat B. Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin. Blood Adv. 2018;2:1315–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Foret T, Dufrost V, Salomon du Mont L, Costa P, Lakomy C, Lagrange J, Lacolley P, Regnault V, Zuily S, Wahl D. Anew pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activatedprotein C resistance. Rheumatology (Oxford). 2022;61(7):2993–2998. https://doi.org/10.1093/rheumatology/keab853. First study to evaluate the relationship between intensity of VKA treatment and APC resistance.

Velasco-Rodríguez D, Laso RV, García-Raso A, et al. Thrombin generation in subjects with lupus anticoagulant without prior thrombosis or gestational morbidities. Thromb Res. 2020;196:425–31.

Article  PubMed